{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_174619.3:c.208G>A",
          "cDNA Change": {
            "transcript": "NM_174619.3",
            "ref": "G",
            "alt": "A",
            "position": "208"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "63"
          },
          "Description in input context": "c.208G>A (p.G63D)"
        }
      ]
    },
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_174619.3:c.786K>E",
          "cDNA Change": {
            "transcript": "NM_174619.3",
            "ref": "K",
            "alt": "E",
            "position": "786"
          },
          "Protein Change": {
            "ref": "K",
            "alt": "E",
            "position": "262"
          },
          "Description in input context": "c.786K>E (p.K262E)"
        }
      ]
    },
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_174619.3:c.913Y>C",
          "cDNA Change": {
            "transcript": "NM_174619.3",
            "ref": "Y",
            "alt": "C",
            "position": "913"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "304"
          },
          "Description in input context": "c.913Y>C (p.Y304C)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0001592"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts and cell lines",
        "Material Name": "HEK293 cells and patient fibroblasts",
        "Description": "Experiments were conducted using HEK293 cells transfected with wild-type or mutant PINK1 constructs, as well as patient-derived fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_174619.3:c.208G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced protein expression levels observed for the G209A variant."
        },
        {
          "Variant": "NM_174619.3:c.786K>E",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Decreased protein stability and reduced kinase activity noted for the K262E variant."
        },
        {
          "Variant": "NM_174619.3:c.913Y>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Impaired ubiquitination activity observed for the Y304C variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each experimental condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate to ensure consistency."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PINK1 cDNA served as the positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as the negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by post-hoc Tukey's test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels greater than 80% of wild-type controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression levels less than 50% of wild-type controls, or significant reduction in enzymatic activity.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Viability Assay",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts and cell lines",
        "Material Name": "HEK293 cells and patient fibroblasts",
        "Description": "The assay was performed using HEK293 cells transfected with wild-type or mutant PINK1 constructs, as well as patient-derived fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_174619.3:c.208G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced cell viability observed for the G209A variant."
        },
        {
          "Variant": "NM_174619.3:c.786K>E",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Decreased cell viability noted for the K262E variant."
        },
        {
          "Variant": "NM_174619.3:c.913Y>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Impaired cell survival observed for the Y304C variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each experimental condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate to ensure consistency."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PINK1 cDNA served as the positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as the negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by post-hoc Tukey's test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability greater than 80% of wild-type controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability less than 50% of wild-type controls, or significant reduction in survival rates.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}